Smartlab Europe

Press Releases

Rentschler Biopharma and Vetter Unveil Xpert Alliance

Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations (CDMOs), announced that the companies are unveiling Xpert Alliance, a joint visualization of their strategic collaboration. The visualization is designed to “bring to life” this ongoing alliance...

BiologIC Technologies and Oxford Biomedica collaborate on novel biocomputer system for viral vector development

BiologIC Technologies, the biocomputer company, has announced today that it has entered into an agreement with Oxford Biomedica, a leading gene and cell therapy group, to collaborate on a novel biocomputer system for viral vector development. BiologIC is the inventor...

Innovent and Lilly Expand Strategic Partnership in Oncology

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, and Eli Lilly and Company ("Lilly",NYSE: LLY) today announced that in light of both...

Gerresheimer opens a new plant to produce pharmaceutical container solutions in Ohio (Berlin)

Gerresheimer ceremoniously took over a new building in Berlin, Ohio. In the future, the square plastic containers of the Duma Twist-Off Q brand with a 40-ml filling volume, child-resistant closure, and desiccant for filling with medications for the North...

DFE Pharma, Harro Hofliger, and Sterling partner in INTO to provide formulation services for respiratory products

Three leading companies in their respective fields - DFE Pharma (excipients solution provider), Harro Höfliger (equipment supplier), and Sterling (API manufacturer) - announced a unique partnership with the establishment of “Inhalation Together” (INTO) in the field of dry powder...

Oasmia Signs Manufacturing Agreement with Lonza for Ovarian Cancer Drug Candidate Cantrixil

Oasmia Pharmaceutical AB, an oncology-focused specialty pharmaceutical company, and Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, announced that the companies have signed a large-scale manufacturing agreement for the main drug intermediate in...

SEQENS Makes Multi-Million-Dollar Investment in U.S. R&D Laboratory

SEQENS, an integrated leader in the manufacturing of active ingredients and pharmaceutical intermediates, announced a multi-million-dollar investment in its research and development laboratory located in Devens, Mass. The improvements will ensure that the new facility will operate at the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »